Related Experiment Video
Updated: Aug 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Implications of comorbidity and ascertainment bias for identifying disease genes
J W Smoller1, K L Lunetta, J Robins
1Harvard School of Public Health, Boston, Massachusetts, USA. jordan_smoller@hms.harvard.edu
Insights
Ascertainment bias in clinical samples can create spurious comorbidity, leading to misleading genetic findings. This bias, where multiple illnesses increase medical seeking, particularly impacts psychiatric genetic studies.
Area of Science:
- Medical Genetics
- Psychiatry
- Biostatistics
Background:
- Comorbidity, the co-occurrence of disorders, is observed at higher rates in clinical samples than population-based samples.
- This difference is often attributed to individuals with multiple conditions being more likely to seek medical care.
Purpose of the Study:
- To define and explain "spurious comorbidity" and "spurious comorbidity bias."
- To demonstrate how this bias can affect genetic association studies, particularly family-based designs.
- To highlight the implications for genetic research in neuropsychiatric disorders.
Main Methods:
- Conceptual explanation of ascertainment bias and its impact on comorbidity.
- Theoretical demonstration of spurious comorbidity bias in family-based association studies.
Main Results:
- Spurious comorbidity arises from ascertainment bias, where seeking care for one condition increases the likelihood of diagnosing a comorbid one.
- Spurious comorbidity bias can lead to incorrect associations between genetic loci and phenotypes.
- This bias can significantly skew conclusions in genetic association studies.
Conclusions:
- Ascertainment bias is a critical factor to consider in genetic studies, especially for complex traits like neuropsychiatric disorders.
- The phenomenon of spurious comorbidity bias may contribute to the challenges in replicating findings in psychiatric genetics.
- Researchers must account for ascertainment bias to ensure the validity of genetic association studies.
Abstract:
Comorbidity, the co-occurrence of disorders, is frequently observed to occur at higher rates in clinically ascertained samples than in population-based samples. An explanation for this finding is that subjects suffering from multiple illnesses are more likely to seek medical care and receive a diagnostic evaluation. We refer to the component of the comorbidity between illnesses due to such ascertainment bias as "spurious comorbidity." When spurious comorbidity is present, an apparent association between a candidate locus and the phenotype of interest may actually be attributable to an association between the locus and a comorbid phenotype. This phenomenon, which we call "spurious comorbidity bias," could thus produce misleading association findings. In this article, we describe this phenomenon and demonstrate that it may produce marked bias in the conclusions of family-based association studies. Because of the extremely high rates of comorbidity among psychiatric disorders in clinical samples, this problem may be particularly salient for genetic studies of neuropsychiatric disorders. We conclude that ascertainment bias may contribute to the frequent difficulty in replicating candidate gene study findings in psychiatry. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:817-822, 2000.
More Related Videos
Related Concept Videos
Genomics
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

